Organogenesis Holdings (ORGO) Earnings Report Date & History

Check the next ORGO earnings date, EPS forecasts, and historical earnings-related price changes

ORGO Earnings Report

Organogenesis Holdings reported earnings of -$ 0.25 per ORGO share on Nov 5, 2026, beating analysts' expectations by 42.86%.Meanwhile, the company posted an EPS of $ 0.0675 during the same period last year, marking a -756.79% change.

Report Date Nov 5, 2026
Forecasted EPS -$ 0.18
Earnings Per Share (Surprise) -$ 0.25   (-$ 0.08)
Last Year's EPS $ 0.0675
EPS YoY Change -756.79%

Organogenesis Holdings Earnings History

Out of the last 43 earnings reporting periods, Organogenesis Holdings beat analysts’ expectations 16 times and fell short of expectations 14 time(s). Organogenesis Holdings reported earnings per share of -$ 0.25 in the last report falling to reach an estimated EPS of -$ 0.18 by 42.86%.

Report Date Forecasted EPS Reported EPS Last Year's EPS EPS YoY Change
Nov 5, 2026 -$ 0.18 -$ 0.25 $ 0.18 -238.89%
Aug 6, 2026 -$ 0.35 -$ 0.71 -$ 0.09 -688.89%
May 7, 2026 -$ 0.29 -$ 0.37 -$ 0.13 -184.62%
Feb 26, 2026 $ 0.215 $ 0.31 $ 0.04 675.00%
Nov 6, 2025 $ 0.21 $ 0.18 $ 0.09 100.00%
Aug 7, 2025 $ 0.07 -$ 0.09 -$ 0.13 30.77%
May 8, 2025 $ 0.04 -$ 0.13 -$ 0.02 -550.00%
Feb 27, 2025 -$ 0.03 $ 0.04 $ 0.00 1,028.07%
Nov 12, 2024 $ 0.01125 $ 0.09 $ 0.02 350.00%
Aug 8, 2024 -$ 0.02 -$ 0.13 $ 0.04 -425.00%
May 9, 2024 -$ 0.02 -$ 0.02 -$ 0.02 0.00%
Feb 29, 2024 $ 0.00 $ 0.00 $ 0.06 -107.18%
Nov 9, 2023 $ 0.01 $ 0.02 $ 0.04 -50.00%
Aug 9, 2023 $ 0.025 $ 0.04 $ 0.07 -42.86%
May 10, 2023 -$ 0.02 -$ 0.02 $ 0.01 -300.00%
Mar 1, 2023 $ 0.05 $ 0.06 $ 0.39 -84.62%
Nov 9, 2022 $ 0.06 $ 0.04 $ 0.10 -60.00%
Aug 9, 2022 $ 0.08 $ 0.07 $ 0.15 -53.33%
May 10, 2022 $ 0.05 $ 0.01 $ 0.07 -85.71%
Mar 1, 2022 $ 0.08 $ 0.39 $ 0.15 160.00%

ORGO Earnings-Related Price Changes

Organogenesis Holdings’s stock was trading at $ 0.87 on Nov 4, 2026 a day before the last earnings report was released.Following the release of the earnings report, ORGO’s price decreased to $ 0.8132 on Nov 6, 2026, recording a -6.53% price change in the 48-hour period.

Report Date EPS Price 1 Day Before Price 1 Day After Change
Nov 5, 2026 -$ 0.25 (42.86%)$ 0.87$ 0.8132-6.53%
Aug 6, 2026 -$ 0.71 (102.86%)$ 2.37$ 1.86-21.52%
May 7, 2026 -$ 0.37 (27.59%)$ 2.56$ 2.37-7.42%
Feb 26, 2026 $ 0.31 (44.19%)$ 4.11$ 3.21-21.90%
Nov 6, 2025 $ 0.18 (-14.29%)$ 3.97$ 5.6341.81%
Aug 7, 2025 -$ 0.09 (-228.57%)$ 4.50$ 4.561.33%
May 8, 2025 -$ 0.13 (-425.00%)$ 5.18$ 3.06-40.93%
Feb 27, 2025 $ 0.04 (-233.33%)$ 3.25$ 6.2191.08%
Nov 12, 2024 $ 0.09 (700.00%)$ 3.50$ 4.4326.57%
Aug 8, 2024 -$ 0.13 (550.00%)$ 2.50$ 2.552.00%
May 9, 2024 -$ 0.02 (25.00%)$ 2.31$ 3.0331.17%
Feb 29, 2024 $ 0.00 (100.47%)$ 3.49$ 2.92-16.33%
Nov 9, 2023 $ 0.02 (100.00%)$ 2.05$ 2.196.83%
Aug 9, 2023 $ 0.04 (60.00%)$ 3.70$ 2.75-25.68%
May 10, 2023 -$ 0.02 (0.00%)$ 2.22$ 2.8829.73%
Mar 1, 2023 $ 0.06 (20.00%)$ 2.45$ 2.7211.02%
Nov 9, 2022 $ 0.04 (-33.33%)$ 3.22$ 2.63-18.32%
Aug 9, 2022 $ 0.07 (-12.50%)$ 6.43$ 4.81-25.19%
May 10, 2022 $ 0.01 (-80.00%)$ 5.62$ 5.884.63%
Mar 1, 2022 $ 0.39 (387.50%)$ 7.44$ 8.7918.15%

FAQs

When does Organogenesis Holdings (ORGO) report earnings?

Organogenesis Holdings released its most recent earnings reports in November 2026, August 2026, May 2026, February 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.

What is Organogenesis Holdings (ORGO) stock EPS forecast?

Organogenesis Holdings missed analysts’ expectations during the last earnings period by 42.86%. Organogenesis Holdings reported earnings of -$ 0.25 per share on Nov 5, 2026, while the forecasted EPS was -$ 0.18

Market Closed

ORGO
Organogenesis Holdings
$ 0.8101
-16.05%   Last 24H
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Updated 2 days ago